市場調查報告書
商品編碼
1423717
到 2030 年 DEXA(雙能量 X光檢測法)市場預測:按類型、技術、應用、最終用戶和地區分類的全球分析Dual Energy X-ray Absorptiometry Market Forecasts to 2030 - Global Analysis By Type (Portable and Standalone), By Technology (Advanced Software, Artificial Intelligence (AI) and Other Technologies), Application, End User and By Geography |
根據 Stratistics 檢測法 的數據,DEXA(雙能)的全球市場預計將達到美元。
DEXA 是一種測量骨骼密度(BMD) 和身體組成的醫學影像技術。使用兩個X光能量水平,可以高精度、低輻射暴露地量化身體特定部位的骨量、脂肪量和瘦肉組織量,從而可以診斷骨質疏鬆症、評估骨折風險,並用於醫療和醫療保健。研究目的。可用於身體組成評估。
據世界衛生組織稱,全球約有 4,100 萬人(即 74%)死於非傳染性疾病和慢性病。根據IOF的一項研究,亞洲骨質疏鬆和骨質缺乏症患者的數量預計到2020年將增加至2.866億,到2050年將增加至5.333億。
骨質疏鬆症和骨骼相關疾病的盛行率增加
骨質疏鬆症和骨骼相關疾病盛行率的增加是 DEXA(雙能量 X光檢測法)市場的關鍵促進因素。人口老化和久坐的生活方式正在增加骨質疏鬆症的盛行率,因此需要早期診斷和監測。 DEXA 能夠準確評估骨骼密度,有助於早期發現骨質疏鬆症,並及時進行干預以降低骨折風險。此外,管理骨骼健康的意識不斷增強,並採取主動措施,全球對 DEXA 系統的需求不斷成長,推動市場成長。
DEXA設備和維護高成本
獲得 DEXA 設備的初始投資是巨大的,這阻礙了小型醫療機構和診所採用該技術。此外,與設備維護、校準和軟體更新相關的持續成本進一步增加了總體擁有成本,限制了可訪問性和採用率,特別是對於預算有限的醫療機構而言,這阻礙了市場成長。
提高對骨骼健康和預防措施的認知
人們對骨質疏鬆症、骨折和相關骨病的認知不斷提高,導致越來越多的人尋求早期診斷方法。這種意識促進了積極主動的醫療方法,並鼓勵定期檢查和骨骼密度評估。因此,醫療保健提供者和診斷中心對 DEXA 掃描的需求不斷成長,越來越多的人優先考慮預防措施和早期檢測以保持最佳的骨骼健康,從而推動市場成長。
輻射暴露問題和監管限制
輻射暴露問題和監管限制對市場構成重大威脅。儘管 DEXA 掃描通常涉及低劑量輻射暴露,但人們的擔憂仍然存在,特別是對孕婦等敏感人群的頻繁篩檢和累積暴露。嚴格的輻射安全法規影響設備的使用和可近性。遵守嚴格的協議、輻射安全措施和培訓要求增加了 DEXA 實施的複雜性和成本。此外,不斷發展的法規可能需要持續的技術進步,以減少輻射,同時保持診斷準確性。
COVID-19 大流行造成骨骼密度掃描等非必要醫療程序的延誤,從而擾亂了市場。由於診所關閉、患者就診減少以及醫療資源用於應對大流行病,DEXA 的獲取受到限制。供應鏈中斷影響了設備製造和分銷,從而影響了市場成長。此外,患者對前往醫療機構就診以及將基本醫療需求置於預防性檢查之上的擔憂加劇了大流行期間的市場動盪。
預計在預測期內,裂縫管理產業將是最大的
由於骨質疏鬆症相關骨折的增加,特別是在人口老化中,骨折治療領域預計將在預測期內成為最大的領域。 DEXA 在評估骨骼健康和骨折風險以及指導骨折管理策略和治療方面發揮重要作用。隨著人們對預防性醫療保健的日益重視以及對早期發現骨骼相關問題的需求不斷增加,預計骨折管理領域的市場將顯著成長。
醫院和診所領域預計在預測期內複合年成長率最高
由於骨質疏鬆症和代謝疾病的診斷需求不斷增加,醫院和診所預計在預測期內將呈現最高成長率。醫院和診所作為初級衛生保健中心,方便患者進行 DEXA 掃描以進行骨骼健康評估。此外,這些設施提供全面的醫療保健服務,對於骨骼密度篩檢和身體組成分析至關重要,這對於各種醫療狀況至關重要,並且正在推動該領域的成長。
由於老年人口不斷成長、醫療基礎設施改善以及骨質疏鬆症和相關疾病盛行率不斷上升,亞太地區正在推動對 DEXA(雙能量 X光檢測法)系統的需求。此外,中國、印度和日本等國家醫療保健支出的增加、技術的進步和政府的支持措施正在促進該地區在 DEXA 市場的主導地位,並帶來巨大的成長機會。
由於醫療保健支出增加、易患骨質疏鬆症的老年人口增加以及對預防性醫療保健的日益關注,預計北美地區將出現顯著成長。此外,醫療保健基礎設施的技術進步和主要市場參與者的存在也有助於該地區的成長潛力。此外,人們對骨骼健康意識的增強以及對早期診斷和治療的重視進一步推動了 DEXA(雙能量 X光檢測法)系統在北美的採用。
According to Stratistics MRC, the Global Dual Energy X-ray Absorptiometry Market is accounted for $619.52 million in 2023 and is expected to reach $1207.26 million by 2030 growing at a CAGR of 10% during the forecast period. Dual-energy X-ray absorptiometry is a medical imaging technique that measures bone mineral density (BMD) and body composition. Using two X-ray energy levels, it quantifies the amount of bone, fat and lean tissue in specific body regions, aiding in diagnosing osteoporosis, assessing fracture risk, and evaluating body composition for medical or research purposes with high precision and low radiation exposure.
According to WHO, non-communicable diseases and chronic diseases account for around 41 Million deaths globally equivalent to 74%. According to IOF research, the number of individuals in Asia with osteoporosis and osteopenia is anticipated to climb to 286.6 million by 2020 and 533.3 million by 2050.
Increasing prevalence of osteoporosis and bone-related disorders
The increasing prevalence of osteoporosis and bone-related disorders acts as a significant driver in the dual-energy X-ray absorptiometry market. With an aging population and sedentary lifestyles, osteoporosis incidence rises, necessitating early diagnosis and monitoring. DEXA's precision in assessing bone mineral density aids in the early detection of osteoporosis, enabling timely intervention to mitigate fracture risks. Additionally, the expanding awareness and proactive measures to manage bone health contribute to the growing demand for DEXA systems globally, driving market growth.
High cost of DEXA equipment and maintenance
The initial investment for acquiring DEXA machines is substantial, deterring smaller healthcare facilities or clinics from adopting this technology. Additionally, ongoing expenses related to equipment maintenance, calibration and software updates further contribute to the overall cost of ownership, limiting accessibility and adoption, particularly for healthcare institutions with constrained budgets, thereby impeding market growth.
Growing awareness of bone health and preventative measures
Heightened consciousness regarding osteoporosis, fractures and related bone disorders prompts individuals to seek early diagnostic methods. This awareness fosters proactive healthcare approaches, encouraging regular screenings and bone density assessments. Consequently, healthcare providers and diagnostic centers witness heightened demand for DEXA scans, driving market growth as more people prioritize preventive measures and early detection to maintain optimal bone health.
Radiation exposure concerns and regulatory constraints
Radiation exposure concerns and regulatory constraints pose a significant threat to the market. While DEXA scans generally involve low radiation doses, concerns persist regarding cumulative exposure, especially in frequent screenings or for sensitive populations like pregnant women. Stringent regulations on radiation safety further impact device usage and accessibility. Compliance with strict protocols, radiation safety measures, and training requirements adds complexity and cost to DEXA implementation. Moreover, evolving regulations may demand continuous technological advancements to reduce radiation while maintaining diagnostic accuracy.
The COVID-19 pandemic disrupted the market by causing delays in non-essential medical procedures, including bone density scans. Clinic closures, reduced patient visits and diverted healthcare resources toward pandemic response limited DEXA utilization. Supply chain disruptions affected equipment manufacturing and distribution, impacting market growth. Moreover, patient concerns about visiting healthcare facilities and prioritizing essential medical needs over preventive screenings further contributed to the market disruption during the pandemic.
The fracture management segment is expected to be the largest during the forecast period
The fracture management segment is anticipated to lead during the forecast period due to rising cases of osteoporosis-related fractures, especially among aging populations. Dual Energy X-ray Absorptiometry plays a crucial role in assessing bone health and fracture risk and guiding fracture management strategies and treatments. With a growing emphasis on preventive healthcare and the need for early detection of bone-related issues, the fracture management segment is projected to witness substantial growth within the market.
The hospitals & clinics segment is expected to have the highest CAGR during the forecast period
The hospitals and clinics segment is anticipated to exhibit the highest growth rate during the forecast period due to increased diagnostic needs for osteoporosis and metabolic disorders. Hospitals and clinics serve as primary healthcare centers, facilitating patient access to DEXA scans for bone health assessments. Moreover, these facilities offer comprehensive healthcare services, making them pivotal for bone density screenings and body composition analyses, which are essential for various medical conditions, driving the segment's growth.
Asia Pacific is poised to lead in market share due to the region's expanding geriatric population, rising healthcare infrastructure and increasing prevalence of osteoporosis and related conditions, which drive the demand for Dual Energy X-ray Absorptiometry (DEXA) systems. Additionally, growing healthcare expenditure, technological advancements and supportive government initiatives in countries like China, India and Japan contribute to the region's dominance in the DEXA market, fostering substantial growth opportunities.
The North American region is poised for substantial growth owing to increasing healthcare expenditure, a rising geriatric population susceptible to osteoporosis and a growing emphasis on preventive healthcare. Additionally, technological advancements in healthcare infrastructure and the presence of key market players contribute to the region's growth potential. Moreover, heightened awareness about bone health and a strong focus on early diagnosis and treatment further drive the adoption of Dual Energy X-ray Absorptiometry systems in North America.
Key players in the market
Some of the key players in Dual Energy X-Ray Absorptiometry Market include Aurora Spine, BeamMed Ltd., Demetech AB, Diagnostic Medical Systems Group, Echolight S.p.A., Eurotec Medical Systems, Furuno Electric Co., Ltd., GE Healthcare, Hologic, Inc., Lone Oak Medical Technologies LLC, Medilink International, Medimaps Group, Osteometer Meditech Inc., OsteoSys Co., Ltd., SCANCO Medical AG, Shenzhen X-ray Equipment Co., Ltd. and Swissray Global Healthcare Holding Ltd.
In September 2023, Medimaps Group, a Swiss/Global med-tech company specializing in image-processing software with AI capabilities for assessing bone health, announced today it received the Medical Device Regulation (MDR) certification from its notified body BSI (CE 2797) for its management system and product portfolio.
In February 2022, Aurora Spine partnered with Echolight Medical, the manufacturer of the radiation-free EchoS portable densitometer utilized to assess the quality of the software platform and the bone mineral density (BMD) in the patients affected. The two companies decided to advertise one other's products to their respective clients and prospects as part of the Aurora DEXA Platform.
Other Technologies